Dose-related interaction between timolol and adrenaline.

Author: OhrströmA

Paper Details 
Original Abstract of the Article :
The effects on IOP of a combination of oral timolol maleate and adrenaline eye drops were investigated in a double-blind randomized trial using health volunteers. Timolol was given in two doses, 20 and 5 mg a day. One percent adrenaline eye drops were given to one eye, placebo to the other. The resu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/BF00407777

データ提供:米国国立医学図書館(NLM)

Timolol and Adrenaline: A Complex Interaction in IOP Management

Glaucoma, a condition characterized by damage to the optic nerve, is a leading cause of blindness. This research investigates the interaction between timolol maleate, a beta-blocker commonly used to lower intraocular pressure (IOP), and adrenaline eye drops, another IOP-lowering agent.

Unveiling the Complexity: Additive and Antagonistic Effects

The study found that the effect of adrenaline on IOP was influenced by the dose of timolol. With a lower dose of timolol, adrenaline had an additive effect, meaning it further lowered IOP. However, with a higher dose of timolol, adrenaline exhibited an antagonistic effect, counteracting the IOP-lowering effects of timolol. This research highlights the complex interactions between these two IOP-lowering agents.

Optimizing Treatment: Tailoring Therapy for Individual Needs

Imagine a world where glaucoma patients can receive tailored treatments that maximize the benefits and minimize the risks of IOP-lowering medications. This research underscores the importance of individualizing treatment plans to account for potential drug interactions. By carefully considering these factors, healthcare providers can optimize treatment strategies and improve the lives of glaucoma patients.

Dr. Camel's Conclusion

This research provides a valuable insight into the intricate interplay between timolol and adrenaline in IOP management. The study's findings suggest that the dose of timolol can significantly influence the effect of adrenaline on IOP. This underscores the need for careful monitoring and dose adjustments to ensure optimal treatment outcomes. By navigating the complexities of drug interactions, we can strive to provide the best possible care for glaucoma patients.

Date :
  1. Date Completed 1981-07-23
  2. Date Revised 2020-03-04
Further Info :

Pubmed ID

6909025

DOI: Digital Object Identifier

10.1007/BF00407777

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.